Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Barve MA"'
Autor:
Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Roland CL; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Bessudo A; California Cancer Associates for Research & Excellence, San Diego, CA, 92127, USA., Gastman BR; Department of Dermatology & Plastic Surgery, Cleveland Clinic, Cleveland, OH, 44195, USA., Villaflor VM; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, 91010, USA., Larson C; EpicentRx, Inc., La Jolla, CA, 92037, USA., Reid TR; EpicentRx, Inc., La Jolla, CA, 92037, USA., Caroen S; EpicentRx, Inc., La Jolla, CA, 92037, USA., Oronsky B; EpicentRx, Inc., La Jolla, CA, 92037, USA. boronsky@epicentrx.com., Stirn M; EpicentRx, Inc., La Jolla, CA, 92037, USA., Williams J; EpicentRx, Inc., La Jolla, CA, 92037, USA., Burbano E; EpicentRx, Inc., La Jolla, CA, 92037, USA., Coyle A; EpicentRx, Inc., La Jolla, CA, 92037, USA., Barve MA; Mary Crowley Cancer Research, Dallas, TX, 75230, USA., Wagle N; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA., Abrouk N; Clinical Trials Innovations, Mountain View, CA, 94040, USA., Kesari S; Pacific Neuroscience Institute and Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA, 90404, USA.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2024 Apr; Vol. 31 (4), pp. 517-526. Date of Electronic Publication: 2023 Dec 25.
Autor:
Blau S; Rainier Hematology Oncology/Northwest Medical Specialties, Seattle, WA., Peguero JA; Department of Research, Oncology Consultants PA, Houston, TX., Moore HCF; Cleveland Clinic, Cleveland, OH., Anderson IC; Providence Medical Group, Santa Rosa, CA., Barve MA; Mary Crowley Cancer Research, Dallas, TX., Cherian MA; The Ohio State University Arthur G. James Cancer Hospital, Columbus, OH., Elkhanany A; University of Alabama at Birmingham, Birmingham, AL., O'Sullivan CC; Mayo Clinic Cancer Center, Rochester, MN., Moreno-Aspitia A; Mayo Clinic Cancer Center, Jacksonville, FL., Plourde P; Sermonix Pharmaceuticals, Columbus, OH., Gleich LL; Medpace, Cincinnati, OH., Riesen K; Medpace, Cincinnati, OH., Ezzati R; Medpace, Cincinnati, OH., Degele M; Tempus Labs, Chicago, IL., Shulman M; Tempus Labs, Chicago, IL., Stempf SD; Tempus Labs, Chicago, IL., Sachse L; Tempus Labs, Chicago, IL., Iyer AA; Tempus Labs, Chicago, IL., Damodaran S; The University of Texas MD Anderson Cancer Center, Houston, TX., Cooney MM; Tempus Labs, Chicago, IL.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Jun; Vol. 7, pp. e2200164.
Autor:
Kesari S; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Bessudo A; California Cancer Associates for Research & Excellence, San Diego, CA 92127, USA., Gastman BR; Department of Dermatology & Plastic Surgery, Cleveland Clinic, Cleveland, OH 44195, USA., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Villaflor VM; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA 91010, USA., Nabell LM; Comprehensive Cancer Center, University of Alabama, Birmingham, AL 35205, USA., Madere D; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Chacon E; Saint John's Cancer Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Spencer C; California Cancer Associates for Research & Excellence, San Diego, CA 92127, USA., Li L; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Larson C; EpicentRx, Inc., La Jolla, CA 92037, USA., Reid T; EpicentRx, Inc., La Jolla, CA 92037, USA., Caroen S; EpicentRx, Inc., La Jolla, CA 92037, USA., Oronsky B; EpicentRx, Inc., La Jolla, CA 92037, USA., Stirn M; EpicentRx, Inc., La Jolla, CA 92037, USA., Williams J; EpicentRx, Inc., La Jolla, CA 92037, USA., Barve MA; Mary Crowley Cancer Research, Dallas, TX 75230, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Sep; Vol. 18 (29), pp. 3245-3254. Date of Electronic Publication: 2022 Aug 11.
Autor:
Ou SI; University of California Irvine School of Medicine and Chao Family Comprehensive Cancer Center, Orange, CA., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Leal TA; University of Wisconsin Carbone Cancer Center, Madison, WI., Rybkin II; Henry Ford Cancer Institute, Detroit, MI., Sabari JK; Perlmutter Cancer Center New York University Langone Health, New York, NY., Barve MA; Mary Crowley Cancer Center, Dallas, TX., Bazhenova L; University of California San Diego, Moores Cancer Center, La Jolla, CA., Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN., Velastegui KL; Mirati Therapeutics, Inc, San Diego, CA., Cilliers C; Mirati Therapeutics, Inc, San Diego, CA., Christensen JG; Mirati Therapeutics, Inc, San Diego, CA., Yan X; Mirati Therapeutics, Inc, San Diego, CA., Chao RC; Mirati Therapeutics, Inc, San Diego, CA., Papadopoulos KP; START San Antonio, San Antonio, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 10; Vol. 40 (23), pp. 2530-2538. Date of Electronic Publication: 2022 Feb 15.
Autor:
Coward JI; ICON Cancer Centre, South Brisbane, QLD 4101, Australia.; School of Medicine, University of Queensland, Brisbane, QLD 4072, Australia., Barve MA; Mary Crowley Cancer Research Center, Dallas, TX 75251, USA., Kichenadasse G; Flinders Medical Centre, Adelaide, SA 5042, Australia., Moore KN; Department of Gynecologic Oncology, University of Oklahoma Health Science Center, Stephenson Cancer Center, Oklahoma City, OK 73104, USA., Harnett PR; Crown Princess Mary Cancer Centre, Westmead, NSW 2145, Australia., Berg D; Formerly of Kazia Therapeutics Ltd., Sydney, NSW 2000, Australia., Garner JS; Kazia Therapeutics Ltd., Sydney, NSW 2000, Australia., Dizon DS; Lifespan Cancer Institute, Providence, RI 02913, USA.; The Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jun 26; Vol. 13 (13). Date of Electronic Publication: 2021 Jun 26.
Autor:
Mato AR; Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: matoa@mskcc.org., Shah NN; Medical College of Wisconsin, Brookfield, WI, USA., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, WA, Australia., Pagel JM; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, USA., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Fakhri B; Division of Hematology and Oncology, University of California, San Francisco, CA, USA., Eyre TA; Churchill Cancer Center, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Patel MR; Florida Cancer Specialists and Sarah Cannon Research Institute, Sarasota, FL, USA., Alencar A; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA., Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Wierda WG; MD Anderson Cancer Center, Houston, TX, USA., Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Gerson JN; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Ghia P; Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy., Le Gouill S; Service d'hématologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France., Lewis DJ; University Hospitals Plymouth NHS Trust, Plymouth, UK., Sundaram S; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Flinn IW; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA., Tam CS; Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia., Barve MA; Mary Crowley Cancer Research Center, Dallas, TX, USA., Kuss B; Flinders University Medical Centre, Bedford Park, SA, Australia., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA., Abdel-Wahab O; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lewis KL; Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, WA, Australia., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Davids MS; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Tan XN; Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, WA, Australia., Fenske TS; Medical College of Wisconsin, Milwaukee, WI, USA., Wallin J; Loxo Oncology at Lilly, Stamford, CT, USA., Tsai DE; Loxo Oncology at Lilly, Stamford, CT, USA., Ku NC; Loxo Oncology at Lilly, Stamford, CT, USA., Zhu E; Loxo Oncology at Lilly, Stamford, CT, USA., Chen J; Loxo Oncology at Lilly, Stamford, CT, USA., Yin M; Loxo Oncology at Lilly, Stamford, CT, USA., Nair B; Loxo Oncology at Lilly, Stamford, CT, USA., Ebata K; Loxo Oncology at Lilly, Stamford, CT, USA., Marella N; Loxo Oncology at Lilly, Stamford, CT, USA., Brown JR; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Wang M; MD Anderson Cancer Center, Houston, TX, USA. Electronic address: miwang@mdanderson.org.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Mar 06; Vol. 397 (10277), pp. 892-901.
Autor:
Rocconi RP; Division of Gynecologic Oncology, University of South Alabama-Mitchell Cancer Institute, Mobile, AL, USA., Grosen EA; Department of Obstetrics and Gynecology, Cancer Care Northwest, Spokane, WA, USA., Ghamande SA; Section of Gynecologic Oncology, Augusta University, Augusta, GA, USA., Chan JK; Division of Gynecologic Oncology, California Pacific/Palo Alto Medical Foundation, Sutter Center Research Institute, San Francisco, CA, USA., Barve MA; Department of Oncology, Mary Crowley Cancer Research Centers, Dallas, TX, USA; Department of Oncology, Texas Oncology, Dallas, TX, USA., Oh J; Department of Oncology, Texas Oncology, Dallas, TX, USA., Tewari D; Department of Obstetrics and Gynecology, Kaiser Permanente, Irvine, CA, USA., Morris PC; Division of Gynecologic Oncology, Nebraska Methodist Hospital, Omaha, NE, USA., Stevens EE; Department of Gynecologic Oncology, Billings Clinic, Billings, MT, USA., Bottsford-Miller JN; Department of Gynecologic Oncology, Billings Clinic, Billings, MT, USA., Tang M; Stats Department, StatBeyond Consulting, Irvine, CA, USA., Aaron P; Department of Medical Affairs, Gradalis, Carollton, TX, USA., Stanbery L; Department of Medical Affairs, Gradalis, Carollton, TX, USA., Horvath S; Department of Site Research, Gradalis, Carollton, TX, USA., Wallraven G; Department of Clinical and Regulatory Operations, Gradalis, Carollton, TX, USA., Bognar E; Department of CMC Operations, Gradalis, Carollton, TX, USA; Department of CMC Operations, Gradalis, Carollton, TX, USA; Department of CMC Operations, Gradalis, Carollton, TX, USA., Manning L; Department of Medical Affairs, Gradalis, Carollton, TX, USA., Nemunaitis J; Department of Medical Affairs, Gradalis, Carollton, TX, USA. Electronic address: jnemunaitis@gradalisinc.com., Shanahan D; Management Department, Gradalis, Carollton, TX, USA; Management Department, Gradalis, Carollton, TX, USA; Management Department, Gradalis, Carollton, TX, USA., Slomovitz BM; Department of Obstetrics and Gynecology, Broward Health, Fort Lauderdale, FL, USA; Department of Obstetrics and Gynecology, Florida International University, Miami, FL, USA., Herzog TJ; Department of Obstetrics and Gynecology, University of Cincinnati Cancer Center, Cincinnati, OH, USA., Monk BJ; Department of Obstetrics and Gynecology, Arizona Oncology, Phoenix, AZ, USA., Coleman RL; US Oncology Research, The Woodlands, TX, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Dec; Vol. 21 (12), pp. 1661-1672.
Autor:
Holmes FA; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology-Houston Memorial City, Houston, Texas., Hellerstedt BA; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology-Austin Central, Austin, Texas., Pippen JE Jr; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas., Vukelja SJ; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology, Tyler, Texas., Collea RP; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; New York Oncology Hematology, Albany, New York., Kocs DM; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology, Round Rock, Texas., Blum JL; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas., McIntyre KJ; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology, Dallas Presbyterian Hospital, Dallas, Texas., Barve MA; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology, Dallas Presbyterian Hospital, Dallas, Texas., Brooks BD; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology, Medical City Dallas, Dallas, Texas., Osborne CR; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas., Wang Y; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas., Asmar L; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas., O'Shaughnessy J; US Oncology Research, McKesson Specialty Health, The Woodlands, Texas.; Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas.
Publikováno v:
Cancer medicine [Cancer Med] 2018 Jun; Vol. 7 (6), pp. 2288-2298. Date of Electronic Publication: 2018 Mar 26.